title: Changes in ventricular 1,2-diacylglycerol content in rats following monocrotaline treatment.
abstract: OBJECTIVE
  1,2-Diacylglycerol may initiate cardiac hypertrophy, probably by activating protein kinase C. To test this hypothesis we determined the 1,2-diacylglycerol content of hypertrophied tissue.
  
  
  METHODS
  Rats were treated with monocrotaline and developed severe right ventricular hypertrophy followed by congestive heart failure. 1,2-Diacylglycerol content and fatty acid composition, DNA concentrations, and RNA concentrations in the right ventricle from monocrotaline treated rats were compared with values obtained from the left side or from control rats.
  
  
  RESULTS
  During the first week, the right ventricle showed no significant change in 1,2-diacylglycerol content and a small increase in RNA concentration. However, the 1,2-diacylglycerol content was significantly increased by 55% at two weeks after monocrotaline injection, when DNA and RNA synthesis was also enhanced to its highest level when compared with control rats (37% and 18%, respectively). At four weeks after monocrotaline injection, conversely, the 1,2-diacylglycerol content was decreased by 25% in the right ventricle from monocrotaline treated rats, most of which had pleural and peritoneal effusions indicating congestive heart failure, although RNA synthesis was sustained at a high level. The fatty acid composition of 1,2-diacylglycerol did not differ significantly between the right and left ventricles or control rat ventricles.
  
  
  CONCLUSIONS
  These results suggest that 1,2-diacylglycerol accumulation is associated with development of hypertrophy in monocrotaline treated rats. In contrast, at a stage of congestive heart failure 1,2-diacylglycerol production decreased, suggesting that intracellular transduction mechanisms may be attenuated.
mesh_terms: D000818:Animals; D006332:Cardiomegaly / Q000139:chemically induced / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004075:Diglycerides / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism; D006333:Heart Failure / Q000139:chemically induced / Q000378:metabolism; D006352:Heart Ventricles; D006976:Hypertension, Pulmonary / Q000139:chemically induced; D050356:Lipid Metabolism; D008297:Male; D016686:Monocrotaline / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism*; D009994:Osmolar Concentration; D012313:RNA / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: C011439:1,2-diacylglycerol; D004075:Diglycerides; D005227:Fatty Acids; D012313:RNA; D016686:Monocrotaline; D004247:DNA